Bloom Michael S, Buck-Louis Germaine M, Schisterman Enrique F, Kostyniak Paul J, Vena John E
Department of Environmental Health Sciences, School of Public Health, University at Albany, State University of New York, One University Place, Rm. #153, Rensselaer, NY 12144, USA.
Environ Res. 2009 Jan;109(1):93-100. doi: 10.1016/j.envres.2008.08.013. Epub 2008 Oct 29.
Investigators often employ a single cross-sectional measure of in utero exposure when evaluating associations between organochlorine (OCs) pesticides/metabolites and adverse reproductive outcomes. Few data are available on the stability of exposures to OCs over critical windows of human reproduction and development inclusive of the periconception window. Our objective was to measures changes in OC concentrations prior to conception and throughout pregnancy or after 12 unsuccessful months attempting pregnancy. Seventy-nine women planning pregnancy were prospectively enrolled and followed for up to 12 menstrual cycles. Blood specimens were obtained for toxicologic analysis of seven OCs from participating women at baseline (preconception, n=79), at the first prenatal visit following a positive pregnancy test leading to a live birth (n=54) or after pregnancy loss (n=10), at approximately 6 weeks post-partum (n=53), and after 12 unsuccessful cycles (n=9). Overall and daily rate of change in OCs concentration (ng/gserum) were estimated adjusting for serum lipids and baseline concentration. Significant (P<0.05) decreases in the overall and daily rate of change in OCs concentrations (ng/mLserum) were observed from baseline to pregnancy for HCB (-0.032, -0.001, respectively) and trans-nonachlor (-0.050, -0.002, respectively) while oxychlordane demonstrated an increase during this critical window (0.029, 0.001, respectively). Significant decreases in aldrin (-0.002, -1.47x10(-4), respectively), HCB (-0.069, -0.003, respectively), and trans-nonachlor (-0.045, -0.002, respectively), and an overall increase for oxychlordane (0.015) were seen for women with pregnancy losses. Significant decreases also were observed among infertile women for aldrin (-0.003, -3.52x10(-6), respectively), DDE (-0.210, -4.29x10(-4), respectively), and HCB (-0.096, -2.03x10(-4), respectively), along with an increase for trans-nonachlor (0.034, 7.59x10(-5), respectively). These data, though limited by sample size and the possibility of laboratory measurement error, suggest that OC concentrations may change over critical windows. This underscores the importance of timing biospecimen collection to critical windows for development in the assessment of reproductive and/or developmental effects.
在评估有机氯(OCs)农药/代谢物与不良生殖结局之间的关联时,研究人员通常采用单一的子宫内暴露横断面测量方法。关于在包括受孕窗口期在内的人类生殖和发育关键阶段,OCs暴露稳定性的数据很少。我们的目标是测量受孕前、整个孕期或在尝试怀孕12个月未成功之后OCs浓度的变化。79名计划怀孕的女性被前瞻性招募,并随访长达12个月经周期。在基线时(受孕前,n = 79)、妊娠试验阳性并成功分娩后的首次产前检查时(n = 54)或妊娠丢失后(n = 10)、产后约6周时(n = 53)以及12个周期未成功怀孕后(n = 9),采集参与研究女性的血液样本进行7种OCs的毒理学分析。对血清脂质和基线浓度进行校正后,估计OCs浓度(ng/g血清)的总体变化率和每日变化率。从基线到孕期,六氯苯(分别为-0.032,-0.001)和反式九氯(分别为-0.050,-0.002)的OCs浓度(ng/mL血清)总体变化率和每日变化率显著降低(P<0.05),而在这个关键阶段,氧氯丹浓度有所升高(分别为0.029,0.001)。妊娠丢失的女性中,艾氏剂(分别为-0.002,-1.47×10⁻⁴)、六氯苯(分别为-0.069,-0.003)和反式九氯(分别为-0.045,-0.002)显著降低,氧氯丹总体升高(0.015)。在不孕女性中,艾氏剂(分别为-0.003,-3.52×10⁻⁶)、滴滴伊(分别为-0.210,-4.29×10⁻⁴)和六氯苯(分别为-0.096,-2.03×10⁻⁴)也显著降低,反式九氯升高(分别为0.034,7.59×10⁻⁵)。这些数据虽然受样本量和实验室测量误差可能性的限制,但表明OCs浓度可能在关键阶段发生变化。这突出了在评估生殖和/或发育影响时,将生物样本采集时间与发育关键阶段相匹配的重要性。